Skip to main content
Erschienen in: Clinical Rheumatology 3/2012

01.03.2012 | Original Article

The pathway of estradiol-induced apoptosis in patients with systemic lupus erythematosus

verfasst von: Maryam Rastin, Mohammad Reza Hatef, Nafisseh Tabasi, Mahmoud Mahmoudi

Erschienen in: Clinical Rheumatology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Systemic lupus erythematosus (SLE) is a disease with unknown etiology. The pathologic role of sex hormones and apoptosis in SLE has often been discussed. We studied the effects of estradiol in the pathway of induced apoptosis in Iranian SLE patients. T lymphocytes from 35 SLE patients and 20 age-matched controls were isolated and cultured in the presence of 10−8 M 17-β estradiol. The expression levels of Fas, Fas ligand (FasL), Bcl-2, caspase-8, and caspase-9 mRNAs were determined semiquantitatively in comparison to the expression level of beta actin RNA. Estradiol exposure did not have any significant effects on the expression levels of Fas, Bcl-2, and caspase-9 in SLE patients and controls. However, the expression levels of FasL and caspase-8 were significantly increased in SLE patients, but not in controls. This suggests the probable involvement of extrinsic apoptosis pathway in estradiol-induced apoptosis in SLE.
Literatur
1.
Zurück zum Zitat Lockshin MD (2002) Sex ratio and rheumatic disease: excerpts from an Institute of Medicine report. Lupus 11:662–666PubMedCrossRef Lockshin MD (2002) Sex ratio and rheumatic disease: excerpts from an Institute of Medicine report. Lupus 11:662–666PubMedCrossRef
2.
Zurück zum Zitat Whitacre CC (2002) Sex differences in autoimmune disease. Nat Immunol 2:777–780CrossRef Whitacre CC (2002) Sex differences in autoimmune disease. Nat Immunol 2:777–780CrossRef
3.
Zurück zum Zitat Funauchi M, Sugiyama M, Sukyoo B et al (2001) A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus. Lupus 10:284–288PubMedCrossRef Funauchi M, Sugiyama M, Sukyoo B et al (2001) A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus. Lupus 10:284–288PubMedCrossRef
4.
Zurück zum Zitat Robal E, Sysa-Jodrzejowska A, Robak T, Smolewski P (2006) Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms. Clin Rheumatol 25:225–233CrossRef Robal E, Sysa-Jodrzejowska A, Robak T, Smolewski P (2006) Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms. Clin Rheumatol 25:225–233CrossRef
5.
6.
Zurück zum Zitat Herrmann M, Voll RE, Kaden JR (2000) Etiopathogenesis of systemic lupus erythematosus. Immunol Today 21(9):424–426PubMedCrossRef Herrmann M, Voll RE, Kaden JR (2000) Etiopathogenesis of systemic lupus erythematosus. Immunol Today 21(9):424–426PubMedCrossRef
7.
Zurück zum Zitat Rider V, Abdou NI (2001) Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol 1:1009–1024PubMedCrossRef Rider V, Abdou NI (2001) Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol 1:1009–1024PubMedCrossRef
8.
Zurück zum Zitat Inui A, Ogasawara H, Naito T, Sekigawa I, Takasaki Y, Hayashida Y, Takamori K, Ogawa H (2007) Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clin Rheumatol 26:1675–1678PubMedCrossRef Inui A, Ogasawara H, Naito T, Sekigawa I, Takasaki Y, Hayashida Y, Takamori K, Ogawa H (2007) Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clin Rheumatol 26:1675–1678PubMedCrossRef
9.
Zurück zum Zitat Shames RS (2002) Gender differences in the development and function of the immune system. J Adoles Health 305:59–70CrossRef Shames RS (2002) Gender differences in the development and function of the immune system. J Adoles Health 305:59–70CrossRef
10.
Zurück zum Zitat Verthelyi D (2001) Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 1:983–993PubMedCrossRef Verthelyi D (2001) Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 1:983–993PubMedCrossRef
11.
Zurück zum Zitat Sekigawa I, Naito T, Hira K et al (2004) Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus 13:217–222PubMedCrossRef Sekigawa I, Naito T, Hira K et al (2004) Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus 13:217–222PubMedCrossRef
12.
Zurück zum Zitat Cutolo M, Capellino S, Sulli A et al (2006) Estrogen and autoimmune diseases. Ann N Y Acad Sci 1089:538–547PubMedCrossRef Cutolo M, Capellino S, Sulli A et al (2006) Estrogen and autoimmune diseases. Ann N Y Acad Sci 1089:538–547PubMedCrossRef
13.
Zurück zum Zitat Zandman-Goddard G, Peeva E, Shoenfeld Y (2007) Gender and autoimmunity. Autoimmun Rev 6:366–372PubMedCrossRef Zandman-Goddard G, Peeva E, Shoenfeld Y (2007) Gender and autoimmunity. Autoimmun Rev 6:366–372PubMedCrossRef
14.
Zurück zum Zitat Rastin M, Hatef MR, Tabasi N, Sheikh A, Morad Abbasi J, Mahmoudi M (2007) Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients. Iran J Immunol 4:110–115PubMed Rastin M, Hatef MR, Tabasi N, Sheikh A, Morad Abbasi J, Mahmoudi M (2007) Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients. Iran J Immunol 4:110–115PubMed
15.
Zurück zum Zitat Jenkins JK, Suwannaroj S, Elbourne KB, Ndebele K, McMurray RW (2001) 17-β estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and Cyclin A. Int Immunopharm 1:1897–1911CrossRef Jenkins JK, Suwannaroj S, Elbourne KB, Ndebele K, McMurray RW (2001) 17-β estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and Cyclin A. Int Immunopharm 1:1897–1911CrossRef
16.
Zurück zum Zitat Wang H, Xu J, Ji X et al (2005) The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell Immunol 235:117–121PubMedCrossRef Wang H, Xu J, Ji X et al (2005) The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell Immunol 235:117–121PubMedCrossRef
17.
Zurück zum Zitat Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F (2006) Abnormal Fas/FasL and caspase-3 mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol 239:121–128PubMedCrossRef Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F (2006) Abnormal Fas/FasL and caspase-3 mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol 239:121–128PubMedCrossRef
18.
Zurück zum Zitat Krueger A, Fas SC, Baumann S, Krammer PH (2003) Role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev 193:58–69PubMedCrossRef Krueger A, Fas SC, Baumann S, Krammer PH (2003) Role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev 193:58–69PubMedCrossRef
19.
Zurück zum Zitat Okasha SA, Ryu S, Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS (2001) Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology 163:49–62PubMedCrossRef Okasha SA, Ryu S, Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS (2001) Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology 163:49–62PubMedCrossRef
20.
Zurück zum Zitat Griffith JS, Jensen SM, Lucenford JK et al (1997) Evidence for the genetic control of estradiol-regulated responses. Am J Pathol 150:2223–2230PubMed Griffith JS, Jensen SM, Lucenford JK et al (1997) Evidence for the genetic control of estradiol-regulated responses. Am J Pathol 150:2223–2230PubMed
21.
Zurück zum Zitat Lorenz HM, Grunke M, Hieronymus T, Kuhnel A, Manger B, Kalden JR (1997) In vitro apoptosis and expression of apoptosis related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 40:306–317PubMedCrossRef Lorenz HM, Grunke M, Hieronymus T, Kuhnel A, Manger B, Kalden JR (1997) In vitro apoptosis and expression of apoptosis related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 40:306–317PubMedCrossRef
22.
Zurück zum Zitat Bijl M, Horst G, Limburg PC, Kallenberg CG (2001) Anti-CD3 induced and anti-Fas induced apoptosis in systemic lupus erythematosus (SLE). Clin Exp Immunol 123:127–135PubMedCrossRef Bijl M, Horst G, Limburg PC, Kallenberg CG (2001) Anti-CD3 induced and anti-Fas induced apoptosis in systemic lupus erythematosus (SLE). Clin Exp Immunol 123:127–135PubMedCrossRef
23.
Zurück zum Zitat Mor G, Sapi E, Abrahams VM et al (2003) Interaction of estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 170:114–122PubMed Mor G, Sapi E, Abrahams VM et al (2003) Interaction of estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 170:114–122PubMed
24.
Zurück zum Zitat Do Y, Ryu S, Nagarkatti M, Nagarkatti PS (2002) Role of death receptor pathway in estradiol-induced T cell apoptosis in vivo. Toxicol Sci 70:63–72PubMedCrossRef Do Y, Ryu S, Nagarkatti M, Nagarkatti PS (2002) Role of death receptor pathway in estradiol-induced T cell apoptosis in vivo. Toxicol Sci 70:63–72PubMedCrossRef
25.
Zurück zum Zitat Bynoe MS, Grimaldi CM, Diamond B (2000) Estrogen up-regulates bcl-2 and blocks tolerance induction of Naïve B cells. Proc Natl Acad Sci USA 97:2703–2708PubMedCrossRef Bynoe MS, Grimaldi CM, Diamond B (2000) Estrogen up-regulates bcl-2 and blocks tolerance induction of Naïve B cells. Proc Natl Acad Sci USA 97:2703–2708PubMedCrossRef
26.
Zurück zum Zitat Cutolo M, Sulli A, Seriolo B, Accardo S, Matti AT (1995) Estrogens, the immune response and autoimmunity. Clin Exp Rheum 13:217–222 Cutolo M, Sulli A, Seriolo B, Accardo S, Matti AT (1995) Estrogens, the immune response and autoimmunity. Clin Exp Rheum 13:217–222
Metadaten
Titel
The pathway of estradiol-induced apoptosis in patients with systemic lupus erythematosus
verfasst von
Maryam Rastin
Mohammad Reza Hatef
Nafisseh Tabasi
Mahmoud Mahmoudi
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 3/2012
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1821-3

Weitere Artikel der Ausgabe 3/2012

Clinical Rheumatology 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.